AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Virtual Seminar on Good Laboratory Practices (GLPs) Comparing and Contrasting GMP - ResearchAndMarkets.com

May 24, 2019

DUBLIN--(BUSINESS WIRE)--May 24, 2019--

The “6-Hour Virtual Seminar on Good Laboratory Practices (GLPs) Comparing and Contrasting GMP” webinar has been added to ResearchAndMarkets.com’s offering.

The objective of this webinar is to compare and contrast between Good Laboratory Practices and Good Manufacturing practices.

Why you should attend

Good Laboratory Practices (GLPs), 21 CFR part 58, are a set of guidelines for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products such as food and color additives, human and animal drugs, medical devices for human use, biological products and electronic products that are regulated by the FDA.

GLPs are enforceable by law. They do not include manufacturing of product. GLPS are for non-clinical laboratory studies in which tests article are studied in test system under laboratory conditions to determine their safety. This does not include studies utilizing human subjects, or clinical studies, or field trials on animals.

Attendees:

  • Quality Assurance Personnel
  • Quality Control Personnel
  • Research and Development Personnel
  • Regulatory Affairs Personnel
  • Project Managers
  • Manufacturing Managers
  • Validation Engineers
  • Internal Auditing Personnel
  • Microbiology Personnel
  • Auditors

Agenda

  • GLP: Good Laboratory Practice
  • GLP is an FDA Regulation
  • Definition of GLPs
  • History of GLPs
  • Why was GLP Created?
  • Objectives of GLP
  • Mission of GLP
  • Instrumentation Validation
  • Analyst Certification
  • Laboratory Certification
  • Grounds for Disqualification
  • Consequences of Noncompliance
  • Reinstatement of a Disqualified Facility
  • References

For more information about this webinar visit https://www.researchandmarkets.com/r/b2pypg

View source version on businesswire.com:https://www.businesswire.com/news/home/20190524005241/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Manufacturing

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/24/2019 11:10 AM/DISC: 05/24/2019 11:10 AM

http://www.businesswire.com/news/home/20190524005241/en

All contents © copyright 2019 The Associated Press.All rights reserved.